` ITCI (Intra-Cellular Therapies Inc) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

ITCI
vs
NOVO B

Over the past 12 months, ITCI has significantly outperformed NOVO B, delivering a return of 75% compared to the NOVO B's 54% drop.

Valuation Comparison

ITCI Intrinsic Value
90.96 USD
Overvaluation 31%
Intrinsic Value
Price
NOVO B Intrinsic Value
628.13 DKK
Undervaluation 28%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Intra-Cellular Therapies Inc
NASDAQ:ITCI
131.87 USD
Novo Nordisk A/S
CSE:NOVO B
450.65 DKK

Financials Comparison

Growth Over Time
ITCI vs NOVO B

ITCI
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Intra-Cellular Therapies Inc
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
ITCI vs NOVO B

ITCI
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Intra-Cellular Therapies Inc
NASDAQ:ITCI
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

ITCI
91.6%
NOVO B
84.3%

Operating Margin

ITCI
-17.1%
NOVO B
44.6%

Net Margin

ITCI
-11%
NOVO B
34.5%

FCF Margin

ITCI
-10.8%
NOVO B
24.5%

ROE

ITCI
-8.6%
NOVO B
88.1%

ROA

ITCI
-7.1%
NOVO B
26.6%

ROIC

ITCI
-42.1%
NOVO B
30.4%

ROCE

ITCI
-13.2%
NOVO B
70%

Stocks Performance

Stocks Performance
ITCI vs NOVO B

Loading
ITCI
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
ITCI vs NOVO B

Loading
ITCI
NOVO B
Difference
www.alphaspread.com

Performance By Year
ITCI vs NOVO B

Loading
ITCI
NOVO B
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account